Top Markets
Coin of the day
Suraksha Diagnostic Ltd. Suraksha Diagnostic Ltd.

Suraksha Diagnostic Ltd.

SURAKSHA
Rangering i aksjer #18533
Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It... Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.
Aksjekurs
$3.75
Markedsverdi
$195.13M
Endring (1 dag)
-0.15%
Endring (1 år)
8.85%
Land
IN
Handel Suraksha Diagnostic Ltd. (SURAKSHA)

Kategori

P/S-forhold for Suraksha Diagnostic Ltd. (SURAKSHA)
P/S-forhold per 2026 TTM: 0
Ifølge Suraksha Diagnostic Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Suraksha Diagnostic Ltd. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter